Find the papers that actually matter

The study of histopathological subtypes is valuable for the personalisation of effective treatment strategies for ovarian cancer. However, increasing diagnostic workloads present a challenge for UK pathology departments, leading to the rise in AI approaches. While traditional approaches in this field have relied on pre-computed, frozen image features, recent advances have shifted towards end-to-end feature extraction, providing an improvement in accuracy but at the expense of significantly reduced scalability during training and time-consuming experimentation. In this paper, we propose a new approach for subtype classification and localisation in ovarian cancer histopathology images using contrastive and prototype learning with pre-computed, frozen features via feature-space augmentations. Compared to DSMIL, our method achieves an improvement of 70.4\% and 15.3\% in F1 score for instance- and slide-level classification, respectively, along with AUC gains of 16.9\% for instance localisation and 2.3\% for slide classification, while maintaining the use of frozen patch features.

Artificial intelligence (AI) can automatically delineate lesions on computed tomography (CT) and generate radiology report content, yet progress is limited by the scarcity of publicly available CT datasets with lesion-level annotations. To bridge this gap, we introduce CT-Bench, a first-of-its-kind benchmark dataset comprising two components: a Lesion Image and Metadata Set containing 20,335 lesions from 7,795 CT studies with bounding boxes, descriptions, and size information, and a multitask visual question answering benchmark with 2,850 QA pairs covering lesion localization, description, size estimation, and attribute categorization. Hard negative examples are included to reflect real-world diagnostic challenges. We evaluate multiple state-of-the-art multimodal models, including vision-language and medical CLIP variants, by comparing their performance to radiologist assessments, demonstrating the value of CT-Bench as a comprehensive benchmark for lesion analysis. Moreover, fine-tuning models on the Lesion Image and Metadata Set yields significant performance gains across both components, underscoring the clinical utility of CT-Bench.

Vision Transformers (ViTs) have emerged as the state-of-the-art architecture in representation learning, leveraging self-attention mechanisms to excel in various tasks. ViTs split images into fixed-size patches, constraining them to a predefined size and necessitating pre-processing steps like resizing, padding, or cropping. This poses challenges in medical imaging, particularly with irregularly shaped structures like tumors. A fixed bounding box crop size produces input images with highly variable foreground-to-background ratios. Resizing medical images can degrade information and introduce artefacts, impacting diagnosis. Hence, tailoring variable-sized crops to regions of interest can enhance feature representation capabilities. Moreover, large images are computationally expensive, and smaller sizes risk information loss, presenting a computation-accuracy tradeoff. We propose VariViT, an improved ViT model crafted to handle variable image sizes while maintaining a consistent patch size. VariViT employs a novel positional embedding resizing scheme for a variable number of patches. We also implement a new batching strategy within VariViT to reduce computational complexity, resulting in faster training and inference times. In our evaluations on two 3D brain MRI datasets, VariViT surpasses vanilla ViTs and ResNet in glioma genotype prediction and brain tumor classification. It achieves F1-scores of 75.5% and 76.3%, respectively, learning more discriminative features. Our proposed batching strategy reduces computation time by up to 30% compared to conventional architectures. These findings underscore the efficacy of VariViT in image representation learning. Our code can be found here: https://github.com/Aswathi-Varma/varivit

Whole slide images (WSIs) are the gold standard for pathological diagnosis and sub-typing. Current main-stream two-step frameworks employ offline feature encoders trained without domain-specific knowledge. Among them, attention-based multiple instance learning (MIL) methods are outcome-oriented and offer limited interpretability. Clustering-based approaches can provide explainable decision-making process but suffer from high dimension features and semantically ambiguous centroids. To this end, we propose an end-to-end MIL framework that integrates Grassmann re-embedding and manifold adaptive clustering, where the manifold geometric structure facilitates robust clustering results. Furthermore, we design a prior knowledge guiding proxy instance labeling and aggregation strategy to approximate patch labels and focus on pathologically relevant tumor regions. Experiments on multicentre WSI datasets demonstrate that: 1) our cluster-incorporated model achieves superior performance in both grading accuracy and interpretability; 2) end-to-end learning refines better feature representations and it requires acceptable computation resources.

The tumor region plays a key role in pathological diagnosis. Tumor tissues are highly similar to precancerous lesions and non tumor instances often greatly exceed tumor instances in whole slide images (WSIs). These issues cause instance-semantic entanglement in multi-instance learning frameworks, degrading both model representation capability and interpretability. To address this, we propose an end-to-end prototype instance semantic disentanglement framework with low-rank regularized subspace clustering, PID-LRSC, in two aspects. First, we use secondary instance subspace learning to construct low-rank regularized subspace clustering (LRSC), addressing instance entanglement caused by an excessive proportion of non tumor instances. Second, we employ enhanced contrastive learning to design prototype instance semantic disentanglement (PID), resolving semantic entanglement caused by the high similarity between tumor and precancerous tissues. We conduct extensive experiments on multicentre pathology datasets, implying that PID-LRSC outperforms other SOTA methods. Overall, PID-LRSC provides clearer instance semantics during decision-making and significantly enhances the reliability of auxiliary diagnostic outcomes.

We introduce a novel uncertainty-aware multimodal segmentation framework that leverages both radiological images and associated clinical text for precise medical diagnosis. We propose a Modality Decoding Attention Block (MoDAB) with a lightweight State Space Mixer (SSMix) to enable efficient cross-modal fusion and long-range dependency modelling. To guide learning under ambiguity, we propose the Spectral-Entropic Uncertainty (SEU) Loss, which jointly captures spatial overlap, spectral consistency, and predictive uncertainty in a unified objective. In complex clinical circumstances with poor image quality, this formulation improves model reliability. Extensive experiments on various publicly available medical datasets, QATA-COVID19, MosMed++, and Kvasir-SEG, demonstrate that our method achieves superior segmentation performance while being significantly more computationally efficient than existing State-of-the-Art (SoTA) approaches. Our results highlight the importance of incorporating uncertainty modelling and structured modality alignment in vision-language medical segmentation tasks. Code: https://github.com/arya-domain/UA-VLS

Skin cancer is one of the most common cancers worldwide and early detection is critical for effective treatment. However, current AI diagnostic tools are often trained on datasets dominated by lighter skin tones, leading to reduced accuracy and fairness for people with darker skin. The International Skin Imaging Collaboration (ISIC) dataset, one of the most widely used benchmarks, contains over 70% light skin images while dark skins fewer than 8%. This imbalance poses a significant barrier to equitable healthcare delivery and highlights the urgent need for methods that address demographic diversity in medical imaging. This paper addresses this challenge of skin tone imbalance in automated skin cancer detection using dermoscopic images. To overcome this, we present a generative augmentation pipeline that fine-tunes a pre-trained Stable Diffusion model using Low-Rank Adaptation (LoRA) on the image dark-skin subset of the ISIC dataset and generates synthetic dermoscopic images conditioned on lesion type and skin tone. In this study, we investigated the utility of these images on two downstream tasks: lesion segmentation and binary classification. For segmentation, models trained on the augmented dataset and evaluated on held-out real images show consistent improvements in IoU, Dice coefficient, and boundary accuracy. These evalutions provides the verification of Generated dataset. For classification, an EfficientNet-B0 model trained on the augmented dataset achieved 92.14% accuracy. This paper demonstrates that synthetic data augmentation with Generative AI integration can substantially reduce bias with increase fairness in conventional dermatological diagnostics and open challenges for future directions.

Accurate polyp segmentation in colonoscopy is essential for cancer prevention but remains challenging due to: (1) high morphological variability (from flat to protruding lesions), (2) strong visual similarity to normal structures such as folds and vessels, and (3) the need for robust multi-scale detection. Existing deep learning approaches suffer from unidirectional processing, weak multi-scale fusion, and the absence of anatomical constraints, often leading to false positives (over-segmentation of normal structures) and false negatives (missed subtle flat lesions). We propose GRAFNet, a biologically inspired architecture that emulates the hierarchical organisation of the human visual system. GRAFNet integrates three key modules: (1) a Guided Asymmetric Attention Module (GAAM) that mimics orientation-tuned cortical neurones to emphasise polyp boundaries, (2) a MultiScale Retinal Module (MSRM) that replicates retinal ganglion cell pathways for parallel multi-feature analysis, and (3) a Guided Cortical Attention Feedback Module (GCAFM) that applies predictive coding for iterative refinement. These are unified in a Polyp Encoder-Decoder Module (PEDM) that enforces spatial-semantic consistency via resolution-adaptive feedback. Extensive experiments on five public benchmarks (Kvasir-SEG, CVC-300, CVC-ColonDB, CVC-Clinic, and PolypGen) demonstrate consistent state-of-the-art performance, with 3-8% Dice improvements and 10-20% higher generalisation over leading methods, while offering interpretable decision pathways. This work establishes a paradigm in which neural computation principles bridge the gap between AI accuracy and clinically trustworthy reasoning. Code is available at https://github.com/afofanah/GRAFNet.

Spatial transcriptomics (ST) provides spatially resolved measurements of gene expression, enabling characterization of the molecular landscape of human tissue beyond histological assessment as well as localized readouts that can be aligned with morphology. Concurrently, the success of multimodal foundation models that integrate vision with complementary modalities suggests that morphomolecular coupling between local expression and morphology can be systematically used to improve histological representations themselves. We introduce Spatial Expression-Aligned Learning (SEAL), a vision-omics self-supervised learning framework that infuses localized molecular information into pathology vision encoders. Rather than training new encoders from scratch, SEAL is designed as a parameter-efficient vision-omics finetuning method that can be flexibly applied to widely used pathology foundation models. We instantiate SEAL by training on over 700,000 paired gene expression spot-tissue region examples spanning tumor and normal samples from 14 organs. Tested across 38 slide-level and 15 patch-level downstream tasks, SEAL provides a drop-in replacement for pathology foundation models that consistently improves performance over widely used vision-only and ST prediction baselines on slide-level molecular status, pathway activity, and treatment response prediction, as well as patch-level gene expression prediction tasks. Additionally, SEAL encoders exhibit robust domain generalization on out-of-distribution evaluations and enable new cross-modal capabilities such as gene-to-image retrieval. Our work proposes a general framework for ST-guided finetuning of pathology foundation models, showing that augmenting existing models with localized molecular supervision is an effective and practical step for improving visual representations and expanding their cross-modal utility.

Language models are widely used in chemistry for molecular property prediction and small-molecule generation, yet Natural Products (NPs) remain underexplored despite their importance in drug discovery. To address this gap, we develop NP-specific chemical language models (NPCLMs) by pre-training state-space models (Mamba and Mamba-2) and comparing them with transformer baselines (GPT). Using a dataset of about 1M NPs, we present the first systematic comparison of selective state-space models and transformers for NP-focused tasks, together with eight tokenization strategies including character-level, Atom-in-SMILES (AIS), byte-pair encoding (BPE), and NP-specific BPE. We evaluate molecule generation (validity, uniqueness, novelty) and property prediction (membrane permeability, taste, anti-cancer activity) using MCC and AUC-ROC. Mamba generates 1-2 percent more valid and unique molecules than Mamba-2 and GPT, with fewer long-range dependency errors, while GPT yields slightly more novel structures. For property prediction, Mamba variants outperform GPT by 0.02-0.04 MCC under random splits, while scaffold splits show comparable performance. Results demonstrate that domain-specific pre-training on about 1M NPs can match models trained on datasets over 100 times larger.